Confident Investing Starts With TipRanks Premium

Get 55% Off
TipRanks
Go Ultimate55% OFF

Enzymatica AB (ENZY) Stock Price & Analysis

0 Followers

ENZY Stock Chart & Stats

kr 2.20-kr 0.10(-4.35%)
At close: 5:30 PM GMT+1
kr 1.75kr 2kr 2.25Aug 10Aug 24Sep 7Sep 21Oct 5Oct 19Nov 2
Day’s Range
SEK 2.20 - SEK 2.30
52-Week Range
SEK 1.55 - SEK 3.40
Previous Close
SEK 2.30
Volume
N/A
Average Volume (3M)
113.61K
Market Cap
SEK 558.29M
Enterprise Value
SEK 422.19M
Total Cash (Recent Filing)
SEK 6.69M
Total Debt (Recent Filing)
SEK 13.80M
Price to Earnings (P/E)
―
Beta
0.01
Next Earnings
Feb 18, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Low Leverage

Low and improving leverage limits balance-sheet debt risk and preserves financial flexibility relative to a highly indebted business. This gives Enzymatica more capacity to manage volatility and allocate resources toward products and operations, although it does not offset current losses.

Solid Gross Margin

A gross margin near 59% indicates the products retain meaningful economic value after direct costs. If maintained, this provides a foundation for operating leverage: stronger revenue could contribute more toward fixed expenses, provided the company can control its oversized operating cost base.

Improving Cash-burn Trajectory

The substantial reduction in operating cash outflows shows that cash performance has improved from recent annual periods. This is a constructive operational trend that could extend runway and reduce funding pressure, but continued negative cash flow means self-sustaining cash generation has not yet been achieved.

Bears Say

Sharp Revenue Contraction

An approximately 85% TTM revenue decline is a major contraction in the commercial base and weakens the scale supporting the business. Persistent revenue deterioration can reduce operating leverage, constrain investment capacity, and make it harder for the company to convert its product platform into durable growth.

Persistent Operating Losses

Very large operating losses and an approximately -81% net margin show that current revenue is insufficient to cover the company’s cost structure. Even with losses narrowing from prior years, prolonged unprofitability can consume capital, limit strategic flexibility, and delay the point at which growth becomes self-funded.

Ongoing Negative Free Cash Flow

Negative operating and free cash flow indicate that the business continues to consume cash through its core activities rather than fund them internally. Ongoing burn creates dependence on funding or a material operating improvement, increasing financial risk if revenue recovery and cost discipline do not arrive together.

ENZY FAQ

What was Enzymatica AB’s price range in the past 12 months?
Enzymatica AB lowest stock price was kr 1.55 and its highest was kr 3.40 in the past 12 months.
What is Enzymatica AB’s market cap?
Enzymatica AB’s market cap is kr 558.29M.
When is Enzymatica AB’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Enzymatica AB’s earnings last quarter?
Enzymatica AB released its earnings results on Oct 29, 2026. The company reported -kr 0.016 earnings per share for the quarter.
Is Enzymatica AB overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Enzymatica AB pay dividends?
Enzymatica AB does not currently pay dividends.
What is Enzymatica AB’s EPS estimate?
Enzymatica AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Enzymatica AB have?
Enzymatica AB has 242,735,100 shares outstanding.
What happened to Enzymatica AB’s price movement after its last earnings report?
Enzymatica AB reported an EPS of -kr 0.016 in its last earnings report. Following the earnings report the stock price went down -0.93%.
Which hedge fund is a major shareholder of Enzymatica AB?
Currently, no hedge funds are holding shares in SE:ENZY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology